Very-long-chain fatty acids activate lysosomal hydrolases in neonatal human skin tissue

Medical Principles and Practice

Volumn 14, Issue SUPPL. 1, 2005, Pages 92-97

  Dhaunsi, Gursev S ^a   Al Essa, Mazen ^a   Muawad, Wisam ^a   Srivastava, Braham S ^a   Rashwan, Nabil ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL SABAH HOSPITAL   (Kuwait)

Author keywords

Catalase; Hydrolases; Lysosomes; Peroxisomes; Very long chain fatty acid

Indexed keywords

ACID LIPASE; ACID PHOSPHATASE; ALPHA GLUCOSIDASE; ALPHA N ACETYLGALACTOSAMINIDASE; ALPHA N ACETYLGLUCOSAMINIDASE; AMINOTRIAZOLE; LIGNOCERIC ACID; LYSOSOME ENZYME; VERY LONG CHAIN FATTY ACID;

CONFERENCE PAPER; CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; MALE; NEWBORN; PREPUCE; PROTEIN EXPRESSION; SKIN CULTURE; WESTERN BLOTTING;

EID: 23844434895     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086190     Document Type: Conference Paper

References (25)

1. Hajra AK, Bishop JE: Glycerolipid biosynthesis in peroxisomes via the acyl dihydroxyacetone phosphate pathway. Ann NY Acad Sci 1982;386:170-182.
2. Lazarow PB, de Duve C: Fatty acyl-CoA oxidizing system in rat liver peroxisomes, enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 1976;73:2043-2046.
3. Dhaunsi GS, Gulati S, Singh AK, Orak JK, Asayama K, Singh I: Demonstration of Cu-Zn superoxide dismutase in rat liver peroxisomes: Biochemical and immunochemical evidence. J Biol Chem 1993;267:6870-6873.
4. Lazarow PB, Moser HW: Disorders of peroxisome biogenesis; in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. New York, McGraw-Hill. 1995, pp 2287-2324.
5. Brown FR, Voigt R, Singh AK, Singh I: Peroxisomal disorders: Neurodevelopmental and biochemical aspects. Am J Dis Child 1993;147:617-626.
6. Wanders RJ, Tager JM: Lipid metabolism in relation to human disease. Mol Aspects Med 1998;19:69-154.
7. Poggi-Travert F, Fournier B, Poll-The BT, Saudubray JM: Clinical approach to inherited peroxisomal disorders. J Inherit Metab Dis 1995;18(suppl):1-18.
8. Schutgens RBH, Heymans HAS, Wanders RJA, Van den Bosch H, Tager JM: Peroxisomal disorders: A newly recognized group of genetic diseases. Eur J Pediatr 1986;144:430-440.
9. Wanders RJ, Heymans HS, Schutgens RB, Barth PG, Van den Bosch H, Tager JM: Peroxisomal disorders in neurology. J Neurol Sci 1988;88:1-39.
10. Kobayashi K, Hayashi M, Nakano H, Fukutani Y, Sasaki K, Shimazaki M, Koshino Y: Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol 2002;28:238-251.
11. Mathews PM, Guerra CB, Jiang Y, Grbovic OM, Kao BH, Schmidt SD, Dinakar R, Mercken M, Hille-Rehfeld A, Rohrer J, Mehta P, Cataldo AM, Nixon RA: Alzheimer's disease-related expression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: Role for altered lysosomal hydrolase distribution in beta-amyloidogenesis. J Biol Chem 2002;277:5299-5307.
12. Pennock CA: Lysosomal storage disorders; in Holton JB (ed): The Inherited Metabolic Diseases, ed 2. New York, Churchill Livingstone, 1994, pp 205-242.
13. Barret AJ, Heath MF: Lysosomal enzymes; in Dingle JT (ed): Lysosomes: A Laboratory Handbook, ed 2. Amsterdam, North Holland, 1977, pp 19-79.
14. Olczyk K, Kucharz EJ, Sonecki P: Matrix-degrading lysosomal hydrolases in serum of rats with hepatic fibrosis treated with methylthiouracil or thyroideum. Rom J Endocrinol 1993;31:23026.
15. Baudhuin P, Beaufay Y, Rahman L, Sellinger OZ, Wattiaux R, Jacques P, de Duve C: Tissue fractionation studies. Biochem J 1964;92:179-184.
16. Ozand PT, Gascon G, Al-Aqeel A, Roberts G, Dhalla M, Subramanyam SB: Prevalence of different types of lysosomal storage diseases in Saudi Arabia. J Inherit Metab Dis 1990;13:849-861.
17. Kamei A, Houdou S, Takashima S, Suzuki Y, Becker LE, Armstrong DL: Peroxisomal disorders in children: Immunohistochemistry and neuropathology. J Pediatr 1993;122:573-579.
18. Moser HW: Peroxisomal disorders. Clin Biochem 1991;24:343-351.
19. Singh I: Peroxisomal fatty acid oxidation and cellular oxidative stress. Methods Enzymol 2002;352:361-372.
20. Adamec E, Mohan PS, Cataldo AM, Vonsattel JP, Nixon RA: Up-regulation of the lysosomal system in experimental models of neuronal injury: Implications for Alzheimer's disease. Neuroscience 2000;100:663-675.
21. Gupta A, Sharma N, Sharma BK, Sharma S, Ganguly NK: Oxygen-dependent and -independent mechanisms of renal injury in experimental ascending pyelonephritis. FEMS Immunol Med Microbiol 1996;13:35-42.
22. Meera R, Anand S, Ramesh CV, Puvanakrishnan R: Inhibition of neutrophil derived lysosomal enzymes and reactive oxygen species by a novel tetrapeptide. Inflamm Res 1999;48:479-484.
23. Boneh A: A model for PKC involvement in the pathogenesis of inborn errors of metabolism. Trends Mol Med 2002;8:524-531.
24. Dickinson DP: Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 2002;13:238-275.
25. Wolters PJ, Chapman HA: Importance of lysosomal cysteine proteases in lung disease. Respir Res 2000;1:170-177.